Mavrilimumab for severe COVID-19

Lancet Rheumatol. 2020 Nov;2(11):e662. doi: 10.1016/S2665-9913(20)30307-6. Epub 2020 Sep 5.

¹ Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, 1985717413, Iran.
² Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, 1985717413, Iran.

No abstract available